NCT00000705View on ClinicalTrials.gov

Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

Not specified

Study Completion Date

March 31, 1989

Conditions
HIV InfectionsHemophilia A
Interventions
DRUG

Zidovudine

Trial Locations (2)

14215

SUNY / Erie County Med Ctr at Buffalo, Buffalo

14642

Univ of Rochester Medical Center, Rochester

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000705 - Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia | Biotech Hunter | Biotech Hunter